Prognostic analysis and risk stratification of lung adenocarcinoma undergoing EGFR-TKI therapy with time-serial CT-based radiomics signature

OBJECTIVES: To evaluate the value of time-serial CT radiomics features in predicting progression-free survival (PFS) for lung adenocarcinoma (LUAD) patients after epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) therapy. MATERIALS AND METHODS: LUAD patients treated with EGFR-T...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaobo, Lu, Bingfeng, Yang, Xinguan, Lan, Dong, Lin, Shushen, Zhou, Zhipeng, Li, Kai, Deng, Dong, Peng, Peng, Zeng, Zisan, Long, Liling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Computed Tomography
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889474/
https://www.ncbi.nlm.nih.gov/pubmed/36166088
http://dx.doi.org/10.1007/s00330-022-09123-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889474/
https://www.ncbi.nlm.nih.gov/pubmed/36166088
http://dx.doi.org/10.1007/s00330-022-09123-5

Ejemplares similares